精准医学杂志2024,Vol.39Issue(5) :463-467.DOI:10.13362/j.jpmed.202405021

卵巢癌铂耐药及其治疗研究进展

Research advances in platinum resistance and its treatment in ovarian cancer

刘妍 黄莉
精准医学杂志2024,Vol.39Issue(5) :463-467.DOI:10.13362/j.jpmed.202405021

卵巢癌铂耐药及其治疗研究进展

Research advances in platinum resistance and its treatment in ovarian cancer

刘妍 1黄莉1
扫码查看

作者信息

  • 1. 莱州市人民医院妇科,山东莱州 261400
  • 折叠

摘要

卵巢癌是恶性程度最高的妇科恶性肿瘤之一.以铂为基础的化疗是卵巢癌治疗的重要组成部分,因此铂耐药也是卵巢癌治疗中棘手的问题.铂耐药是一个复杂的过程,涉及多种机制.本文就卵巢癌细胞铂耐药的分子机制及治疗进展作一综述,以期为该病的临床治疗提供借鉴.

Abstract

Ovarian cancer is one of the most malignant gynecological tumors.Platinum-based chemotherapy is an impor-tant part of ovarian cancer treatment,with platinum resistance as a difficult problem in ovarian cancer treatment.Platinum resis-tance is a complex process involving a variety of mechanisms.This article reviews the molecular mechanisms of platinum resistance in ovarian cancer cells and the advances in treatment,in order to provide a reference for the clinical treatment of this disease.

关键词

卵巢肿瘤//抗肿瘤药/抗药性,肿瘤/综述

Key words

Ovarian neoplasms/Platinum/Antineoplastic agents/Drug resistance,neoplasm/Review

引用本文复制引用

出版年

2024
精准医学杂志
青岛大学

精准医学杂志

ISSN:2096-529X
段落导航相关论文